CRIS - Curis, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.694
-0.006 (-0.886%)
As of 3:35PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.700
Open0.710
Bid0.692 x 200
Ask0.695 x 11600
Day's Range0.685 - 0.729
52 Week Range0.670 - 3.220
Volume956,125
Avg. Volume1,731,511
Market Cap113.772M
Beta2.05
PE Ratio (TTM)N/A
EPS (TTM)-0.395
Earnings DateMar 7, 2018 - Mar 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

    The dose escalation stage of the trial will enroll patients with relapsed/refractory non-Hodgkin's lymphoma, and the expansion stage will focus on specific populations of patients with lymphomas harboring alterations in the MYD88 gene or Toll-like receptor (TLR) signaling pathway. "We are pleased to announce the advancement of our clinical pipeline with the initiation of the Phase 1 trial for this selective IRAK kinase inhibitor in patients with lymphomas," commented Ali Fattaey, Ph.D., Curis's president and CEO.

  • Investopedia15 days ago

    Top 3 Healthcare Penny Stocks for 2018

    These three healthcare penny stocks are poised for positive performance in 2018.

  • Capital Cube28 days ago

    ETFs with exposure to Curis, Inc. : December 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Curis, Inc. Here are 5 ETFs with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Want To Invest In Curis Inc (NASDAQ:CRIS)? Here’s How It Performed Lately
    Simply Wall St.last month

    Want To Invest In Curis Inc (NASDAQ:CRIS)? Here’s How It Performed Lately

    Examining Curis Inc’s (NASDAQ:CRIS) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations, whichRead More...

  • Capital Cubelast month

    ETFs with exposure to Curis, Inc. : December 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Curis, Inc. Here are 5 ETFs with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Investopedialast month

    Top 3 Healthcare Penny Stocks for 2017

    These three healthcare penny stocks are poised for positive performance in the remainder of 2017.

  • GlobeNewswire2 months ago

    Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

    LEXINGTON, Mass., Dec. 01, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced ...

  • Capital Cube2 months ago

    ETFs with exposure to Curis, Inc. : November 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Curis, Inc. Here are 5 ETFs with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Should You Be Concerned About Curis Inc’s (CRIS) Investors?
    Simply Wall St.2 months ago

    Should You Be Concerned About Curis Inc’s (CRIS) Investors?

    I am going to take a deep dive into Curis Inc’s (NASDAQ:CRIS) most recent ownership structure, not a frequent subject of discussion among individual investors. When it comes to ownershipRead More...

  • 24/7 Wall St.2 months ago

    Merck, Cardinal Health Drop into Monday’s 52-Week Low Club

    Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.

  • Capital Cube2 months ago

    ETFs with exposure to Curis, Inc. : November 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Curis, Inc. Here are 5 ETFs with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CRIS earnings conference call or presentation 7-Nov-17 1:30pm GMT

    Q3 2017 Curis Inc Earnings Call

  • Curis, Inc. :CRIS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
    Capital Cube2 months ago

    Curis, Inc. :CRIS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Curis, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Curis, Inc. – Exelixis, Inc., Infinity Pharmaceuticals, Inc., Emergent BioSolutions Inc., Spectrum Pharmaceuticals, Inc., Celldex Therapeutics, Inc., Pfizer Inc., Celgene Corporation and Bristol-Myers Squibb Company (EXEL-US, INFI-US, EBS-US, SPPI-US, ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Curis, Inc. : November 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Curis, Inc. Here are 5 ETFs with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Investopedia2 months ago

    Top 3 Healthcare Penny Stocks for 2017

    These three healthcare penny stocks are poised for positive performance in the remainder of 2017.

  • What Does Curis Inc’s (CRIS) Share Price Indicate?
    Simply Wall St.2 months ago

    What Does Curis Inc’s (CRIS) Share Price Indicate?

    Curis Inc (NASDAQ:CRIS), a biotechnology company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGM, rising to the highs of $2.16Read More...

  • Associated Press2 months ago

    Curis reports 3Q loss

    The Lexington, Massachusetts-based company said it had a loss of 11 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...

  • ACCESSWIRE2 months ago

    Curis, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Curis, Inc. (NASDAQ: CRIS ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 8:30 AM Eastern Time. To ...

  • ACCESSWIRE3 months ago

    Curis, Upcoming SITC Meeting, Aurigene Collaboration and Analysts Review

    NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • GlobeNewswire3 months ago

    Curis to Present at the Society for Immunotherapy of Cancer 32nd Annual Meeting and the Cowen IO NEXT Summit

    LEXINGTON, Mass., Nov. 03, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced ...

  • What You Must Know About Curis Inc’s (CRIS) Financial Strength
    Simply Wall St.3 months ago

    What You Must Know About Curis Inc’s (CRIS) Financial Strength

    Investors are always looking for growth in small-cap stocks like Curis Inc (NASDAQ:CRIS), with a market cap of USD $262.21M. However, an important fact which most ignore is: how financiallyRead More...

  • GlobeNewswire3 months ago

    Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017

    LEXINGTON, Mass., Nov. 01, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...

  • Investopedia3 months ago

    Top 3 Healthcare Penny Stocks for 2017

    These three healthcare penny stocks are poised for positive performance in the remainder of 2017.

  • Why Curis Inc (CRIS) Could Be A Buy
    Simply Wall St.4 months ago

    Why Curis Inc (CRIS) Could Be A Buy

    Curis Inc (NASDAQ:CRIS), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a decent share price growth in the teens level on the NasdaqGM over the lastRead More...